Remember the Name of a Given DrugNCT05343234
Drug Name Identification an Ignored Patient's Problem That Needs a Solution
A study of Remember the Name of a Given Drug, run by Alexandria University at 1 site in Egypt.
Trial summary
Each of the recruited patient was given 3 different placebo drugs with 3 different mad up names to be taken for one month with different regiments. The drug name resembled a real drug but with enough difference to prevent the patient from trying to buy it as a safety precaution. Read more about this study
- Who is it for?
- Ages 20 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Remember the Name of a Given Drug
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 500 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Apr 2022to Jun 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- ASA I and II patients
Who cannot join
- severe or life-threatening condition
- severe visual impairment
- mental or cognitive dysfunction
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Alexandria university
Alexandria, 0203
Mohamed M osman, 01006357996, yasseralx@hotmail.com
Yasser m osman, assist prof
About this study
Each of the recruited patient was given 3 different placebo drugs with 3 different mad up names to be taken for one month with different regiments.
The drug name resembled a real drug but with enough difference to prevent the patient from trying to buy it as a safety precaution. The name was printed on the box in English and Arabic letters. The coloured shape was printed to 2x2 cm dimension.
Read more
After one month the participants were intervened by a doctor blinded to the study. The doctor asked about the drug history of the patient. If the participant could remember the drug name and its correct regiment the doctor documented that. if the patent failed to remember the correct name and its regiment then the doctor asked the patient to try and remember anything about the drug.
Then the patient would be asked about the symbol on the drug and was it helpful for him in any way.
Read the detailed description
A scoring system was used to evaluate pateints memory of the drugs used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the patient could remember the name of the tree drugs correctly.
The same scoring system was used for the symbols
- Conditions
- Remember the Name of a Given Drug
- Being tested
- Placebo
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PlaceboDrug
Also called placebo drugs
tree different placebo drugs with tree different names and scheduled will be given
| Study group | Role | What they receive |
|---|---|---|
| patients receiving the placebo medication | Experimental | tree different placebo drugs with tree different names and symbols one will be given twice daily one once in the morning one once before bedtime Receives: Drug: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
score for remembering the drug name
A scoring system was used to evaluate patients memory of the drugs name used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the patient could remember the name of the tree drugs correctly.
Measured: memory will be tested after one month from prescribing the drugs
score for remembering the drug symbol
A scoring system was used to evaluate patients memory of the drugs symbol used 0- 3 0 is the minimal score and will be given if no recall of any drug symbol and 3 is the maximum score and will be given if the patient could remember the symbol of the tree drugs correctly.
Measured: memory will be tested after one month from prescribing the drugs
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Apr 2022
- Study start1 Apr 2022
- Primary completionJun 2022 (estimated)
- Study completionJun 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Remember the Name of a Given DrugStudies of the same condition, open and under way.
- More trials run by Alexandria UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Alexandria University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- yasser M osman, Principal investigator, Alexandria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05343234
- Sponsor's protocol ID
- 0305534
- Status last verified
- Apr 2022
- First submitted
- 17 Apr 2022
- Last updated
- 25 Apr 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Apr 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Drug Name Identification an Ignored Patient's Problem That Needs a Solution
- ClinicalTrials.gov ID
- NCT05343234
- Acronym / sponsor ID
- 0305534
- Conditions
- Remember the Name of a Given Drug
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Alexandria UniversityUniversity, hospital or other
- Study start
- 1 Apr 2022 (actual)
- Primary completion
- Jun 2022 (estimated)
- Study completion
- Jun 2022 (estimated)
- First posted
- 25 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Each of the recruited patient was given 3 different placebo drugs with 3 different mad up names to be taken for one month with different regiments.
The drug name resembled a real drug but with enough difference to prevent the patient from trying to buy it as a safety precaution. The name was printed on the box in English and Arabic letters. The coloured shape was printed to 2x2 cm dimension.
After one month the participants were intervened by a doctor blinded to the study. The doctor asked about the drug history of the patient. If the participant could remember the drug name and its correct regiment the doctor documented that. if the patent failed to remember the correct name and its regiment then the doctor asked the patient to try and remember anything about the drug.
Then the patient would be asked about the symbol on the drug and was it helpful for him in any way.
Detailed description
A scoring system was used to evaluate pateints memory of the drugs used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the patient could remember the name of the tree drugs correctly.
The same scoring system was used for the symbols
Study design
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| patients receiving the placebo medication | Experimental | Drug: Placebotree different placebo drugs with tree different names and symbols one will be given twice daily one once in the morning one once before bedtime |
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- ASA I and II patients
Key exclusion criteria (3 listed)
- severe or life-threatening condition
- severe visual impairment
- mental or cognitive dysfunction
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PlaceboAlso: placebo drugstree different placebo drugs with tree different names and scheduled will be given | Drug | patients receiving the placebo medication |
Primary outcome
score for remembering the drug name
Time frame: memory will be tested after one month from prescribing the drugs
A scoring system was used to evaluate patients memory of the drugs name used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the patient could remember the name of the tree drugs correctly.
score for remembering the drug symbol
Time frame: memory will be tested after one month from prescribing the drugs
A scoring system was used to evaluate patients memory of the drugs symbol used 0- 3 0 is the minimal score and will be given if no recall of any drug symbol and 3 is the maximum score and will be given if the patient could remember the symbol of the tree drugs correctly.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Apr 2022.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
yasser M osman principal investigator
Alexandria University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study of Remember the Name of a Given Drug, run by Alexandria University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact yasser M osman (+201006357996, yasseralx@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
score for remembering the drug name (time frame: memory will be tested after one month from prescribing the drugs). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2022; AzTrials last refreshed its copy on 1 Nov 2026.